Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 63629-2239

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide (NDC 63629-2239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636292239)

Label (Lbl636292239)
This is a description of a medication called Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets. Each tablet contains 20mg Olmesartan Medoxomil, 6.9mg Amlodipine Besylate, and 12.5mg Hydrochlorothiazide. It is important to keep this medication out of reach of children, store it at a temperature between 20° to 25° C (68° to 77° F) and dispense it in a tightly sealed, light-resistant container. The medication is only available with an Rx and comes with 90 tablets.*
FDA Label Image

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)

FDA Label Image

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)

FDA Label Image

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)

FDA Label Image

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)

FDA Label Image

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.